ASX - By Stock
|
MSB Biotech |
Re:
MSB AGM - confidence restored
|
|
zztop99
|
304 |
94K |
0 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
304
|
94K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
For the Number Crunches
|
|
zztop99
|
14 |
4.1K |
8 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
14
|
4.1K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
zztop99
|
953 |
294K |
2 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
953
|
294K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB $1 Party
|
|
zztop99
|
1.1K |
360K |
5 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
1.1K
|
360K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for that 55% surge?
|
|
zztop99
|
44 |
12K |
11 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
44
|
12K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for that 55% surge?
|
|
zztop99
|
44 |
12K |
0 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
44
|
12K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
zztop99
|
1.0K |
283K |
1 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
283K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
zztop99
|
1.0K |
283K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
1.0K
|
283K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
3 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NEJM CHF Imminent
|
|
zztop99
|
270 |
83K |
2 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
270
|
83K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
0 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
2 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
3 |
02/09/21 |
02/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
zztop99
|
145 |
42K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
145
|
42K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
zztop99
|
206 |
63K |
6 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
63K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
zztop99
|
206 |
63K |
14 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
63K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
zztop99
|
206 |
63K |
49 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
63K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Would this ever fly?
|
|
zztop99
|
21 |
7.3K |
2 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
21
|
7.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Would this ever fly?
|
|
zztop99
|
21 |
7.3K |
5 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
21
|
7.3K
|
5
|
|
ASX - By Stock
|
MSB |
Guess the date of the Next Announcement
|
|
zztop99
|
8 |
2.4K |
2 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
8
|
2.4K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
zztop99
|
157 |
47K |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
157
|
47K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
0 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
zztop99
|
344 |
101K |
6 |
17/08/21 |
17/08/21 |
ASX - By Stock
|
344
|
101K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
zztop99
|
1.5K |
420K |
3 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
1.5K
|
420K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
zztop99
|
423 |
129K |
1 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
423
|
129K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
|
|
zztop99
|
423 |
129K |
1 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
423
|
129K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
0 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
zztop99
|
11K |
3.5M |
0 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
11K
|
3.5M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Regulatory Pathways - where we stand with the FDA
|
|
zztop99
|
74 |
26K |
3 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
74
|
26K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
0 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
9 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
zztop99
|
427 |
134K |
4 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
427
|
134K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
zztop99
|
427 |
134K |
3 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
427
|
134K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
zztop99
|
427 |
134K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
427
|
134K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
zztop99
|
427 |
134K |
0 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
427
|
134K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
zztop99
|
260 |
82K |
2 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
260
|
82K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
$90 a share on COVID ARDS Authorization ?
|
|
zztop99
|
260 |
82K |
4 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
260
|
82K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Stuart Robert's Pitt Street Report
|
|
zztop99
|
289 |
50K |
1 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
289
|
50K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
zztop99
|
1.5K |
510K |
6 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.5K
|
510K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
zztop99
|
1.5K |
420K |
0 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.5K
|
420K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Moderated
|
|
zztop99
|
1.5K |
510K |
0 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
1.5K
|
510K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Risk management
|
|
zztop99
|
95 |
23K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
95
|
23K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
zztop99
|
300 |
87K |
2 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
87K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
zztop99
|
300 |
87K |
4 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
87K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
zztop99
|
1.5K |
420K |
1 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
1.5K
|
420K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
zztop99
|
982 |
288K |
5 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
982
|
288K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
zztop99
|
982 |
288K |
0 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
982
|
288K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast - all set to boom
|
|
zztop99
|
243 |
91K |
1 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
243
|
91K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
zztop99
|
1.6K |
469K |
20 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
20
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
zztop99
|
10K |
3.0M |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|